<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03537079</url>
  </required_header>
  <id_info>
    <org_study_id>38RC17.347</org_study_id>
    <nct_id>NCT03537079</nct_id>
  </id_info>
  <brief_title>Hypoxic Conditioning in Heart Failure</brief_title>
  <acronym>hypoxheart</acronym>
  <official_title>Hypoxic Conditioning Combined With Exercise Training in Heart Failure Patient: a Randomised, Controled, Single Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure impairs quality of life and exercise capacity, despite an optimal medical
      therapy. Alternative methods, like hypoxic conditioning coupled to exercise training, must be
      explored and describe
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All heart failure patients will have a session of 45' of bicycle exercise training (in
      normoxia or hypoxia) AND a one hour rest session (in normoxia or hypoxia).

      Exercise training sessions will consist in a continue bicycle exercise test at 70 to 80 % of
      the maximal heart rate, while breathing (single blind) normoxia or hypoxia gaz.

      Rest conditioning consist in a one hour of rest, while breathing (single blind) normoxia or
      hypoxia gaz.

      For hypoxia sessions, the oxygen saturation target will be fo 85-90 % for the 4 first weeks
      and 80-85 % for the last 4 weeks.

      Three arms :

        -  exercise training in NORMOXIA and rest conditioning in NORMOXIA

        -  exercise training in HYPOXIA and rest conditioning in NORMOXIA

        -  exercise training in NORMOXIA and rest conditioning in HYPOXIA
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2018</start_date>
  <completion_date type="Anticipated">April 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>this is a single blind study patients don't know if they are breathing normal air (normoxia) or hypoxic air (hypoxia).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>maximal oxygen uptake in ml/min/kg</measure>
    <time_frame>after 8 weeks of training and conditioning</time_frame>
    <description>The maximal exercise capacity will be assessed by an incremental maximal bicycle exercise test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>End diastolic left ventricle diameter in mm</measure>
    <time_frame>After 8 weeks of training and conditioning</time_frame>
    <description>In parasternal long axe, the end diastolic left ventricle diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic left ventricle ejection fraction in %</measure>
    <time_frame>After 8 weeks of training and conditioning</time_frame>
    <description>the systolic left ventricle ejection fraction will be assessed by Simpson's method in 4 and 2 cavity views</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>flow mediated dilatation (FMD) in %</measure>
    <time_frame>After 8 weeks of training and conditioning</time_frame>
    <description>The rest FMD will be assessed by echocardiography by using the % of variation of the brachial artery diameter 10 minutes after occlusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic and diastolic blood pressure control in mmHg</measure>
    <time_frame>After 8 weeks of training and conditioning</time_frame>
    <description>24 hours ambulatory blood pressure monitoring</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>normoxia conditioning</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>exercise training in normoxia and rest conditioning in normoxia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>exercise hypoxia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise training in hypoxia and rest conditioning in normoxia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rest hypoxia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise training in normoxia and rest conditioning in hypoxia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypoxia air</intervention_name>
    <description>Normobaric hypoxia is generated by adding azote in normal air to decrease the oxygen availability.</description>
    <arm_group_label>normoxia conditioning</arm_group_label>
    <arm_group_label>exercise hypoxia</arm_group_label>
    <arm_group_label>rest hypoxia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient available for exercise training

          -  stable heart failure state I-II New York Heart Association (NYHA) with altered
             ejection fraction (EF ≤ 40 %)

          -  signed informed consent

        Exclusion Criteria:

          -  unstable ischemic cardiopathy

          -  right ventricle dysfunction

          -  uncontrolled arrythmias

          -  rest elevated in pulmonary artery pressure (≥ 45 mmHg)

          -  migraine

          -  high altitude trip above 2500 m high during study period

          -  impossibility to realise a maximal bicycle exercise test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>stephane doutreleau, MD, PhD</last_name>
    <phone>+ 33 4 76 76 77 73</phone>
    <email>sdoutreleau@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>samuel verges, PhD</last_name>
    <phone>+ 33 4 76 76 54 94</phone>
    <email>sverges@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>stephane doutreleau, MD, PhD</last_name>
      <phone>+33 4 76 76 77 73</phone>
      <email>sdoutreleau@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>samuel verges, PhD</last_name>
      <phone>+ 33 4 76 76 54 94</phone>
      <email>sverges@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2018</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Grenoble</investigator_affiliation>
    <investigator_full_name>S Doutreleau, MD</investigator_full_name>
    <investigator_title>Principal Invstigator</investigator_title>
  </responsible_party>
  <keyword>hypoxia</keyword>
  <keyword>exercise training</keyword>
  <keyword>heart failure</keyword>
  <keyword>cardiac remodeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

